-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang High-tech Industrial Development Zone Court Judges Provide “Law-Bringing” Services to Enterprises
Category:
发布时间：2020-04-23
【概要描述】
On the morning of April 22, three judges from the People’s Court of the Shijiazhuang High-tech Industrial Development Zone visited Shijiazhuang Sihua Pharmaceutical Co., Ltd. to conduct a field survey on the company’s legal service needs during its resumption of work and production.
On the morning of April 22, three judges from the People’s Court of the Shijiazhuang High-tech Industrial Development Zone visited Shijiazhuang Sihua Pharmaceutical Co., Ltd. to conduct a fact-finding mission on the company’s legal service needs during its resumption of work and production.
At the High-tech Zone plant, the judges went straight to the production floor, gaining a thorough understanding of the manufacturing process for intravenous infusion preparations. They also held detailed discussions with Shi Jianhui, Secretary of the Party Committee of Shijiazhuang No. 4 Pharmaceutical Co., Ltd., and Wang Hongliang, Deputy General Manager of the Company’s Operations Division, about the company’s pharmaceutical production and supply during the epidemic prevention and control efforts, as well as its contributions to these efforts. The judges highly commended the company for demonstrating a strong sense of social responsibility in the face of the pandemic.
During the symposium, the judges carefully reviewed the legal issues encountered by enterprises in their production and business operations. The judges stated that they would further fulfill their official duties, promptly solicit enterprises’ requests and suggestions, strengthen outreach of legal services to the grassroots level, and strive to provide robust legal support for the development of enterprises in the High-tech Zone.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091